Electrophysiological consequences of vincristine contained chemotherapy in children: A cohort study

Journal of Pediatric Neurology

Volumn 7, Issue 4, 2009, Pages 351-356

  Toopchizadeh, Vahideh ^a   Barzegar, Mohammad ^a   Rezamand, Azim ^a   Feiz, Abbasali Hosseinpoor ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute lymphoblastic leukemia; Children; Neuropathy; Vincristine

Indexed keywords

VINCRISTINE;

ACTION POTENTIAL; ACUTE LYMPHOBLASTIC LEUKEMIA; ARM; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; ELECTROPHYSIOLOGY; FEMALE; HUMAN; LEG; MALE; MOTOR NERVE; NERVE CONDUCTION; NEUROPATHY; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 70350786697     PISSN: 13042580     EISSN: 18759041     Source Type: Journal    
DOI: 10.3233/JPN-2009-0333     Document Type: Article

References (23)

1. J.F. Margolin, C.P. Steuber and D.G. Poplack, Acute lymphoblastic leukemia, in: Principles and Practice of Pediatric Oncology, (5th ed.), P.A. Pizzo and D.G. Poplack, eds, Philadelphia: Lippincott Whiliams & Wilkins, 2006, pp. 538-590.
2. K.S. Topp, K.D. Tanner and J.D. Levine, Damage to the cytoskeletone of large diameter sensory neurons and myelinated axons in vincristine induced painful peripheral neuropathy in the rat, J Comp Neurol 424 (2000), 563-576.
3. J.J. Ochs, Neurotoxicity due to central nervous system therapy for childhood leukemia, Am J Pediatr Hematol Oncol 11 (1989), 93-105.
4. M. Ray, R.K. Marwaha and A. Trehan, Chemotherapy related fatal neurotoxicity during induction in acute lymphoblastic leukemia, Indian J Pediatr 69 (2002), 185-187.
5. M.H. Cheok and W.E. Evans, Acute lymphoblastic leukaemia: A model for the pharmacogenomics of cancer therapy, Nat Rev Cancer 6 (2006), 117-129.
6. A.A. Amato and D. Dimitru, Aquired neuropathies, in: Electrodiagnostic Medicine, (2nd ed.), D. Dimitru, A.A. Amato and M.J. Zwarts, eds, Philadelphia: Hanley & Belfos, 2002, pp. 989-998.
7. D. Dumitru, A.A. Amato and J.R. Machiel, Nerve conduction study, in: Electrodiagnostic Medicine, (2nd ed.), D. Dimitru, A.A. Amato and M.J. Zwarts, eds, Philadelphia: Hanley & Belfos, 2002, pp. 159-217.
8. L. Vainionpää, Clinical neurological findings of children with acute lymphoblastic leukemia at diagnosis and during treatment, Eur J Pediatr 152 (1993), 115-119.
9. S. Kroczka, M. Kaciñski, S. Skoczeñ and W. Balwierz, Electroneurophysiological and clinical consequences of therapy of acute lymphoblastic leukemia in children, Przegl Lek 60 (2003), 48-53, (in Polish).
10. S.M. Watkins and J.P. Griffin, High incidence of vincristine-induced neuropathy in lymphomas, Br Med 1 (1978), 610-612.
11. H.A. Reinders-Messelink, T.W. Van Weerden, J.M. Fock et al., Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia, Eur J Paediatr Neurol 4 (2000), 225-233.
12. N. Authier, J.P. Gillet, J. Fialip, A. Eschalier and F. Coudore, A new animal model of vincristine-induced nociceptive peripheral neuropathy, Neurotoxicology 24 (2003), 797-805.
13. P.K. Pal, Clinical and electrophysiological studies in vincristine induced neuropathy, Electromyogr Clin Neurophysiol 39 (1999), 323-330.
14. L. Vainionpää, T. Kovala, U. Tolonen and M. Lanning, Vincristine therapy for children with acute lymphoblastic leukemia impairs condution in the entire peripheral nerve, Pediatr Neurol 13 (1995), 314-318.
15. L. Vainionpää, T. Kovala, U. Tolonen and M. Lanning, Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials, Med Pediatr Oncol 28 (1997), 41-47.
16. E. Ferrante and A. Savino, Clinico-electrophysiological study of vincristine neuropathy, Study of 6 leukemic children, Riv Neurol 60 (1990), 131-136, (In Italian).
17. T.J. Postma, J.J. Heimans, M.J. Muller, G.J. Ossenkoppele, J.B. Vermorken and N.K. Aaronson, Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy, Ann Oncol 9 (1998), 739-744.
18. C. Airiau, Drug -induced neuropathies: Review, J Pharm Clin 18 (1999), 90-94.
19. P.C. Contreras, J.L. Vaught, J.A. Gruner et al., Insulin-like growth factor-I prevents development of a vincristine neuropathy in mice, Brain Res 774 (1997), 20-26.
20. E.B. Casey, A.M. Jellife, P.M. Le Quesne and Y.L. Millett, Vincristine neuropathy, Clinical and electrophysiological observations, Brain 96 (1973), 69-86.
21. M. Hussain, A.J. Wozniak and M.B. Edelstein, Neurotoxicity of antineoplastic agents, Crit Rev Oncol Hematol 14 (1993), 61-75.
22. J.C. Allen, The effects of cancer therapy on the nervous system, J Pediatr 93 (1978), 903-909.
23. W.G. Bradley, L.P. Lassman, G.W. Pearce and J.N. Walton, The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies, J Neurol Sci 10 (1970), 107-131.